Fundamental Analysis of Integra LifeSciences HLDG - Growth / Value Index
IART - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.104
Tsr Value Index - Poor Score of 29.69
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 54.25 | 21.94 | 72.21 % | |
| Price to Book | 1.34 | 1.39 | 9.31 % | 1.34 |
| Price to Sales | 1.43 | 1.43 | -2.86 % | |
| Enterprise Value to EBITDA Multiple | 26.33 | 12.62 | 50.76 % |
IART - Profitability Highlights
Profitability Analysis
Company Earning excess return
Piotroski F Score - Stable Value of 5.0
Tsr Profitability Index - Very Poor Score of 5.62
In the last three years, the company has given poor Returns on Assets
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 2.48 | 6.35 | -36.52 % | -0.205 |
| Return On Asset | 1.05 | 2.67 | -42.55 % | -0.080 |
| Net Profit Margin | 2.63 | 6.54 | -43.59 % | -0.889 |
| Operating Profit Margin | 6.47 | 9.29 | -39.43 % | 1.07 |
| EBITDA Margin | 8.46 | 17.72 | -27.69 % | 1.07 |
Highlights
| Market Cap | 2170.14 M |
| Enterprise Value | 3408.57 M |
| Price/Book TTM | 1.34 |
| Outstanding Share | 78799.70 K |
| Float/ Outstanding Share | 85.90% |
| Dividend Yield | 1.46 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.83 |
| Peter Lynch Ratio | -0.773 |
| Piotroski F Score | 5.00 |
| Altman Z Score | 1.72 |
| Sloan Ratio | -0.0174 |
| Peter Lynch Fair Value | 0 |
IART - Growth Highlights
Growth Analysis
Tsr Growth Index - Poor Score of 24.05
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1529.60 M | 0.970 % | 7.09 % |
| Gross Profit | 1366.54 M | 6.39 % | 57.65 % |
| EBITDA | 129462 K | 28.39 % | 95.41 % |
| Net Profit | 40234.00 K | 44.14 % | 116.54 % |
| EPS | 0.508 | 41.93 % | NA |
IART - Stability Highlights
Stability Analysis
Altman Z Score of 1.70 suggest high risk
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.954 | 27.21 % | 0.0223 |
| Cash Ratio | 1.01 | -29.24 % | |
| Quick Ratio | 2.18 | -16.51 % | 3.35 |
| Shareholders Equity | 41.99 | -9.49 % | |
| Debt to EBITDA | 5.54 | 56.32 % |
Historical Valuation Ratios of Integra LifeSciences HLDG
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Integra LifeSciences HLDG
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Integra LifeSciences HLDG
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Integra LifeSciences HLDG
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)